Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ultrasound may help doctors give fluids more safely in sepsis

NCT ID NCT06879249

Disease control Sponsor: Shusheng Li Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether using ultrasound to guide fluid management could improve outcomes in 118 sepsis patients in the ICU. Doctors used ultrasound to check blood flow and heart function before deciding how much fluid to give. The goal was to see if this approach could lower death rates and reduce organ damage compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
critical ultrasonography (device)
What this could lead to
If successful, this approach could help doctors give fluids more precisely to sepsis patients, potentially reducing deaths and organ failure.
What could go wrong
This is a small, single-center study with 118 patients. Results may not apply to all hospitals or patients, and the benefit over standard care is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

118 people

The number who actually took part.

Started

Apr 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 1\. Age ≥ 18 years old; * 2\. Estimated length of ICU stay ≥ 24 hours; * 3\. Diagnosis according to the Sepsis 3.0 criteria, which included: * a. suspected or confirmed infections supported by clinical evidence and/or positive microbiological findings; * b. the sepsis related organ failure assessment (SOFA) score ≥ 2. Exclusion Criteria: * 1\. Patients were pregnant woman; * 2\. Patients had acute coronary syndrome; * 3\. Patients had acute pulmonary edema; * 4\. Patients had status asthmatics; * 5\. Patients had malignant arrhythmia; * 6\. Patients had active gastrointestinal bleeding; * 7\. Patients had epileptic seizure; * 8\. Patients had drug poisoning; * 9\. Patients had severe burns; * 10\. Patients had contraindications of blood transfusion; * 11\. Patients had intra-abdominal hypertension (intra-abdominal pressure increases continuously ≥ 12mmHg); * 12\. Patients had acute pulmonary embolism; * 13\. Patients had contraindications of leg raising; * 14\. Patients had cardiac structural or functional abnormalities (left ventricular outflow tract obstruction, moderate-to-severe mitral regurgitation, aortic regurgitation), it would seriously affect the velocity time integral of left ventricular outflow tract; * 15\. Patients or their legal representatives refused active treatment; * 16\. Patients or their legal representatives refused to participate in this study; * 17\. Patients were participating in other interventional clinical trials.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sepsis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sepsis

Contacts and locations

Locations

  • Department of Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, 430030, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.